デフォルト表紙
市場調査レポート
商品コード
1464659

診断用特殊抗体市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Diagnostic Specialty Antibodies Market, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 322 Pages
納期
2～3営業日
カスタマイズ可能
診断用特殊抗体市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月01日
発行: AnalystView Market Insights
ページ情報: 英文 322 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

レポートハイライト

診断用特殊抗体の市場規模は2023年に279億1,000万米ドルとなり、2024年から2032年にかけてCAGR 5.23%で拡大

診断用特殊抗体市場- 市場力学

感染症や慢性疾患の増加が市場の成長を促進する見込み

がん、心血管疾患、糖尿病、自己免疫疾患などの慢性疾患の有病率が増加しています。診断用特殊抗体は、これらの疾患の正確な診断とモニタリングに不可欠です。米国疾病管理センター（Centers for Disease Control）の報告によると、慢性疾患は米国におけるヘルスケア費用の約75％を占め、1人当たり年間5,300米ドルに上ると推定されています。さらに、新興市場ではヘルスケアのインフラが改善し、医療支出が増加しているため、診断用特殊抗体市場の世界の拡大には大きなチャンスがあります。とはいえ、これらの抗体の市場開拓と検証にかかる高いコストが市場成長の妨げになる可能性もあります。

診断用特殊抗体市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約5.23%のCAGRで毎年成長すると推定されます。

製品タイプ別では、モノクローナル抗体が2023年に最大の市場シェアを示すと予測されています。

用途別では、感染症診断薬が2023年の主要タイプでした。

エンドユーザー別では、病院が2023年の主要タイプでした。

地域別では、北米が2023年の主要収益源でした。

診断用特殊抗体市場-セグメンテーション分析：

診断用特殊抗体の世界市場は、製品タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品タイプによって3つに区分される：モノクローナル抗体、ポリクローナル抗体、組み換えポリクローナル抗体です。モノクローナル抗体が市場で最大のシェアを占めています。モノクローナル抗体は診断用特殊抗体市場において不可欠であり、幅広い診断目的に対して卓越した特異性と再現性を提供します。

市場は用途別に6つのセグメントに分類される：肝炎診断薬、結核診断薬、デング熱診断薬、腫瘍診断薬、HIV診断薬、感染症診断薬、その他です。感染症診断薬が市場で最大のシェアを占めています。診断用特殊抗体の世界市場は、感染症の流行の高まり、迅速かつ正確な診断検査に対するニーズの高まり、抗体技術の進歩などを背景に、継続的な成長を遂げています。

市場はエンドユーザー別に診断ラボ、病院、その他に区分されます。病院が市場の主役です。病院では最先端の診断技術や個別化医療戦略の導入が進んでおり、診断用特殊抗体のニーズは高まり、医療診断の進歩やブレークスルーを促進すると予測されます。

診断用特殊抗体市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカにまたがっています。これらの地域は、事業活動に貢献している国によってさらに区分されます。同市場は、医療インフラが確立されている北米が大きくリードしています。同地域は、政府、民間保険会社、個人がヘルスケアサービスや製品に多額の投資を行っており、世界的に見ても最も高いヘルスケア支出水準を誇っています。2022年、米国の医療費は4.1％増加し、総額4兆5,000億米ドル、国民1人当たり1万3,493米ドルとなった。米国の医療支出は、国内総生産の17.3％を占めている（National Health Expenditure Accounts（NHEA）による）。北米に次いで、欧州が予測期間中に市場成長する第2位の地域となった。これは、自己検査キットの人気の高まりと、感染症をターゲットとした検査キットの規制承認の増加によるものです。

診断用特殊抗体市場-競合情勢：

カスタム抗体開発・作製サービス市場では、各社が診断アッセイ開発者や研究者に個別化ソリューションを提供することで際立とうと努力しています。これらのソリューションには、抗体のデザイン、生産、精製、結合、バリデーションなど様々な側面が含まれます。プロバイダーは、その技術的専門知識、厳格な品質保証措置、卓越した顧客サポートによって他社との差別化を図っています。市場は、新規抗体技術や診断アッセイを継続的に導入する革新的な新興企業やバイオテクノロジー企業の存在によってさらに活性化されています。これらの企業は、ニッチ市場に特化したり、新たな診断ニーズに対応したり、独自の抗体プラットフォームを保有したりしています。新興企業は多くの場合、破壊的技術を提供し、迅速な技術革新サイクルを維持し、柔軟なビジネスモデルを採用することで競争優位性を獲得しています。

目次

第1章 診断用特殊抗体市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 診断用特殊抗体の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 診断用特殊抗体産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 診断用特殊抗体市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 診断用特殊抗体市場情勢

  • 診断用特殊抗体市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 診断用特殊抗体市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • モノクローナル抗体
    • ポリクローナル抗体
    • 組み換えポリクローナル抗体

第8章 診断用特殊抗体市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 肝炎診断
    • 結核診断
    • デング熱診断
    • 腫瘍診断
    • HIV診断
    • 感染症診断
    • その他

第9章 診断用特殊抗体市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 診断検査室
    • 病院
    • その他

第10章 診断用特殊抗体市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 診断用特殊抗体業界

  • 競合ダッシュボード
  • 企業プロファイル
    • F. Hoffmann-La Roche AG
    • Abcam PLC
    • Abbott Laboratories
    • Bio-Rad Laboratories Inc.
    • Agilent Technologies Inc.
    • Creative Diagnostics
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson and Company
    • Merck KGaA
    • Sartorius AG
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Diagnostic Specialty Antibodies Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Diagnostic Specialty Antibodies Market, by Product Type 2019-2032 (USD Million)
  • TABLE Diagnostic Specialty Antibodies Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Diagnostic Specialty Antibodies Market, by Application 2019-2032 (USD Million)
  • TABLE Diagnostic Specialty Antibodies Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Diagnostic Specialty Antibodies Market, by End-User 2019-2032 (USD Million)
  • TABLE Diagnostic Specialty Antibodies Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Diagnostic Specialty Antibodies Market, by Region 2019-2032 (USD Million)
  • TABLE North America Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Specialty Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Specialty Antibodies Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Specialty Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Specialty Antibodies Market, by End-User, 2019-2032 (USD Million)
目次
Product Code: ANV2461

REPORT HIGHLIGHT

Diagnostic Specialty Antibodies Market size was valued at USD 27,910 Million in 2023, expanding at a CAGR of 5.23% from 2024 to 2032.

Diagnostic specialty antibodies are a type of antibodies that have been specifically designed and are used for diagnostic purposes in different medical and scientific fields. These antibodies are highly precise in targeting their intended molecules, which allows for accurate detection and measurement. They typically recognize unique epitopes on the molecules they are targeting, ensuring that there is minimal interference from other substances. Diagnostic antibodies find applications in various diagnostic techniques such as enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC), western blotting, flow cytometry, and immunofluorescence. By helping to identify and quantify specific analytes in biological samples, these antibodies play a crucial role in the diagnosis and monitoring of diseases.

Diagnostic Specialty Antibodies Market- Market Dynamics

Rise in occurrence of Infectious and chronic diseases are expected to propel the growth of market

Chronic illnesses like cancer, cardiovascular diseases, diabetes, and autoimmune disorders are increasing in prevalence. Diagnostic specialty antibodies are essential for precise diagnosis and monitoring of these conditions. The Centers for Disease Control reports that chronic diseases contribute to approximately 75 percent of healthcare expenses in the United States, amounting to an estimated USD5300 per person per year. Additionally, as healthcare infrastructure improves and healthcare spending rises in emerging markets, there is considerable opportunity for the global expansion of the diagnostic specialty antibodies market. Nevertheless, the high costs associated with the development and validation of these antibodies may hinder market growth.

Diagnostic Specialty Antibodies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.23% over the forecast period (2024-2032)

Based on product type segmentation, Monoclonal Antibodies was predicted to show maximum market share in the year 2023

Based on application segmentation, Infectious Disease Diagnostics was the leading type in 2023

Based on End User segmentation, Hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Diagnostic Specialty Antibodies Market- Segmentation Analysis:

The Global Diagnostic Specialty Antibodies Market is segmented on the basis of Product Type, Application, End-User, and Region.

The market is segmented into three categories according to product type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies. Monoclonal Antibodies hold the largest share in the market. Monoclonal antibodies are essential in the diagnostic specialty antibodies market, providing exceptional specificity and reproducibility for a wide range of diagnostic purposes.

The market is categorized into six segments based on application: Hepatitis Diagnostics, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, Infectious Disease Diagnostics, and Others. Infectious Disease Diagnostics holds the largest share in the market. The global market for diagnostic specialty antibodies is witnessing continuous growth, driven by the rising prevalence of infectious diseases, the rising need for quick and precise diagnostic tests, and advancements in antibody technology.

The market is segmented into two categories according to End-User: Diagnostic Laboratories, Hospitals, Others. Hospitals are the dominant force in the market. With hospitals increasingly embracing cutting-edge diagnostic technologies and personalized medicine strategies, the need for diagnostic specialty antibodies is projected to rise, fueling progress and breakthroughs in healthcare diagnostics.

Diagnostic Specialty Antibodies Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is predominantly led by North America, attributed to its well-established healthcare infrastructure. The region boasts one of the highest healthcare expenditure levels globally, with substantial investments from governments, private insurers, and individuals in healthcare services and products. In 2022, U.S. health care spending increased by 4.1 percent, totaling USD4.5 trillion or USD13,493 per capita. Health spending in the U.S. accounted for 17.3 percent of the nation's Gross Domestic Product, as reported by the National Health Expenditure Accounts (NHEA). Following North America, Europe emerges as the second-largest region for market growth during the forecast period, driven by the rising popularity of self-testing kits and the growing number of regulatory approvals for test kits targeting infectious diseases.

Diagnostic Specialty Antibodies Market- Competitive Landscape:

In the market for custom antibody development and production services, companies strive to stand out by offering personalized solutions to diagnostic assay developers and researchers. These solutions encompass various aspects such as antibody design, production, purification, conjugation, and validation. Providers distinguish themselves through their technical expertise, stringent quality assurance measures, and exceptional customer support. The market is further fueled by the presence of innovative startups and biotechnology firms that continuously introduce novel antibody technologies and diagnostic assays. These companies may specialize in niche markets, address emerging diagnostic needs, or possess proprietary antibody platforms. Startups often gain a competitive edge by offering disruptive technologies, maintaining rapid innovation cycles, and adopting flexible business models.

Recent Developments:

On April 17, 2020, Roche announced the development and forthcoming release of its Elecsys Anti-SARS-CoV-2 serology test designed to identify antibodies in individuals who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) responsible for causing the COVID-19 illness.

The FDA has issued two emergency use authorizations (EUAs) to Abbott this week, permitting diagnostic and antibody tests to be conducted on the company's Alinity systems. Nowadays, the agency granted authorization for Abbott's COVID-19 molecular diagnostic test to be used on its new Alinity m molecular laboratory instrument. Abbott has initiated the rollout of the Alinity m system to customers in the United States.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL Diagnostic Specialty Antibodies MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

F. Hoffmann- La Roche AG

Abcam PLC

Abbott Laboratories

Bio-Rad Laboratories Inc.

Agilent Technologies Inc.

Creative Diagnostics

Thermo Fisher Scientific Inc.

Becton, Dickinson and Company

Merck KGaA

Sartorius AG

Others

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Polyclonal Antibodies

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hepatitis Diagnostics
  • Tuberculosis Dignostics
  • Dengue DiaGnostic
  • Oncology Diagnostic
  • HIV Diagnostic
  • Infectious Disease Diagnostics
  • Others

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY End-User- MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Laboratories
  • Hospitals*
  • Others

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Diagnostic Specialty Antibodies Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Diagnostic Specialty Antibodies Market Snippet by Product Type
    • 2.1.2.Diagnostic Specialty Antibodies Market Snippet by Application
    • 2.1.3.Diagnostic Specialty Antibodies Market Snippet by End-User
    • 2.1.4.Diagnostic Specialty Antibodies Market Snippet by Country
    • 2.1.5.Diagnostic Specialty Antibodies Market Snippet by Region
  • 2.2.Competitive Insights

3.Diagnostic Specialty Antibodies Key Market Trends

  • 3.1.Diagnostic Specialty Antibodies Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Diagnostic Specialty Antibodies Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Diagnostic Specialty Antibodies Market Opportunities
  • 3.4.Diagnostic Specialty Antibodies Market Future Trends

4.Diagnostic Specialty Antibodies Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Diagnostic Specialty Antibodies Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Diagnostic Specialty Antibodies Market Landscape

  • 6.1.Diagnostic Specialty Antibodies Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Diagnostic Specialty Antibodies Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Monoclonal Antibodies
    • 7.1.3.Polyclonal Antibodies
    • 7.1.4.Recombinant Polyclonal Antibodies

8.Diagnostic Specialty Antibodies Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Hepatitis Diagnostics
    • 8.1.3.Tuberculosis Dignostics
    • 8.1.4.Dengue DiaGnostic
    • 8.1.5.Oncology Diagnostic
    • 8.1.6.HIV Diagnostic
    • 8.1.7.Infectious Disease Diagnostics
    • 8.1.8.Others

9.Diagnostic Specialty Antibodies Market - By End-User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2.Diagnostic Laboratories
    • 9.1.3.Hospitals*
    • 9.1.4.Others

10.Diagnostic Specialty Antibodies Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Diagnostic Specialty Antibodies Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Diagnostic Specialty Antibodies Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Diagnostic Specialty Antibodies Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Diagnostic Specialty Antibodies Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Diagnostic Specialty Antibodies Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Diagnostic Specialty Antibodies Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.F. Hoffmann- La Roche AG
    • 11.2.2.Abcam PLC
    • 11.2.3.Abbott Laboratories
    • 11.2.4.Bio-Rad Laboratories Inc.
    • 11.2.5.Agilent Technologies Inc.
    • 11.2.6.Creative Diagnostics
    • 11.2.7.Thermo Fisher Scientific Inc.
    • 11.2.8.Becton, Dickinson and Company
    • 11.2.9.Merck KGaA
    • 11.2.10.Sartorius AG
    • 11.2.11.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us